Theory Paper IDrNB Cardiology – Theory Notes
VSD DEVICE CLOSURE: CURRENT STATUS
IANATOMICAL SUITABILITY
- Muscular VSD: Ideal for device closure due to being surrounded by a thick muscular rim. Most common indication.
- Perimembranous VSD (pmVSD): Technically feasible but controversial due to the proximity of the Tricuspid valve and the Bundle of His.
- Doubly Committed Subarterial VSD: Generally not suitable for device closure as it lacks a superior rim and risks causing Aortic Valve prolapse/regurgitation.
- Post-MI VSD: High-risk surgical patients. Device closure acts as a bridge to surgery or a primary therapy, though tissue fragility makes it challenging.
IIINDICATIONS FOR CLOSURE
- Hemodynamic Significance: Left-to-right shunt with Qp:Qs ratio of 1.5 to 1 or higher.
- Left Heart Overload: Progressive Left Atrial or Left Ventricular enlargement on echocardiography.
- History of Endocarditis: Regardless of the shunt size.
- Symptomatic Patients: Failure to thrive (infants), dyspnea, or reduced exercise tolerance.
- Pulmonary Hypertension: Indicated if Pulmonary Vascular Resistance is less than 3 Wood Units.
IIIPROCEDURAL TECHNIQUES
- Arteriovenous (AV) Loop: The standard technique. A wire is passed from the arterial side, through the VSD, into the venous system, and snared to create a stable rail for device delivery.
- Imaging: Transesophageal Echocardiography (TEE) or Intracardiac Echocardiography (ICE) is used alongside fluoroscopy to guide placement.
- Device Selection:
- Amplatzer Muscular VSD Occluder: Double-disc nitinol device with a thick waist to match the muscular septum.
- Amplatzer Membranous VSD Occluder: Specifically shaped to avoid interference with the heart valves.
- Amplatzer Duct Occluder (ADO I / ADO II): Frequently used “off-label” for certain perimembranous defects to minimize conduction system pressure.
IVCOMPLICATIONS AND LIMITATIONS
- Complete Heart Block (CHB): The most significant risk in perimembranous VSD closure (up to 5 percent). Can occur acutely or as a late complication due to mechanical compression of the AV node.
- Tricuspid/Aortic Regurgitation: Caused by device interference with valve leaflets or subvalvular apparatus.
- Device Embolization: Risk is higher in large defects with inadequate muscular rims.
- Vascular Injury: Significant risk in small children due to the large sheath sizes required for the AV loop.
- Hemolysis: High-velocity residual shunting through or around the device can cause mechanical red cell destruction.
VCURRENT EVIDENCE AND OUTCOMES
- Muscular VSD: Device closure is the established gold standard with success rates exceeding 95 percent and minimal complications.
- Perimembranous VSD: Remains a debated topic. While technically successful, the risk of permanent pacemaker implantation leads many centers to prefer surgery in young children.
- Post-MI VSD: Early device closure is associated with high mortality due to necrotic tissue, but delayed closure (after 3 to 4 weeks) shows significantly better outcomes as the tissue becomes fibrotic.
meritmedscript.comDr. Sidhartha Mullapudi
